FDA warns Serena Williams migraine drug ad is misleading

The FDA has just written a letter to pharma-giant AbbVie, asking the company to cease running an advertisement for a migraine drug that features tennis legend Serena Williams. The letter details that the advertisement for Ubrelvy 'makes false or misleading representations' about the drug, and might lead migraine patients to believe that, 'all patients who take Ubrelvy can expect their migraine pain to be eliminated after a single dose of Ubrelvy, when this has not been demonstrated'.
Read More >> Full Article on Source: MAG NEWS
#US #ShowBiz #Sports #Politics #Celebs #Shannon #Springfield Ohio #HE'S MINE #HudutsuzSevda #Social Security #Haitians to Venezuela

CORR MAG

FDA warns Serena Williams migraine drug ad is misleading